Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | dihydrodiol dehydrogenase, putative | 0.0036 | 0.0108 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0036 | 0.0108 | 0.0108 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0036 | 0.0108 | 0.0108 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 0.8471 | 0.8471 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.019 | 0.0098 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0036 | 0.0108 | 0.0128 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0036 | 0.0108 | 0.0128 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0036 | 0.0108 | 0.0128 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0036 | 0.0108 | 0.0128 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0036 | 0.0108 | 0.0108 |
Trypanosoma brucei | aldo-keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Echinococcus multilocularis | aldo keto reductase | 0.0036 | 0.0108 | 0.0108 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0366 | 0.0984 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0036 | 0.0108 | 0.0108 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.0537 | 0.1636 |
Trypanosoma cruzi | aldo/keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0036 | 0.0108 | 0.0108 |
Giardia lamblia | Aldose reductase | 0.0036 | 0.0108 | 0.5 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0036 | 0.0108 | 0.0128 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0366 | 0.0984 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.019 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0036 | 0.0108 | 0.0108 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.0537 | 0.0634 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0036 | 0.0108 | 0.0128 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Mycobacterium leprae | PROBABLE OXIDOREDUCTASE | 0.0036 | 0.0108 | 0.0181 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0166 | 0.0069 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0036 | 0.0108 | 0.0108 |
Trichomonas vaginalis | aldo/keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Mycobacterium tuberculosis | Probable isocitrate lyase AceAa [first part] (isocitrase) (isocitratase) (Icl) | 0.0594 | 0.596 | 1 |
Trichomonas vaginalis | aldo/keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0345 | 0.0284 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.019 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.2728 | 1 |
Trichomonas vaginalis | dihydrodiol dehydrogenase, putative | 0.0036 | 0.0108 | 0.5 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.2728 | 0.3221 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0537 | 0.0512 |
Echinococcus multilocularis | aldo keto reductase | 0.0036 | 0.0108 | 0.0108 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0537 | 0.0512 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.019 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0366 | 0.0984 |
Giardia lamblia | Aldose reductase | 0.0036 | 0.0108 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0537 | 0.0512 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0537 | 0.0512 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.0537 | 0.1636 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0166 | 0.0221 |
Onchocerca volvulus | 0.0058 | 0.0345 | 1 | |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0036 | 0.0108 | 0.0128 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.019 | 0.0098 |
Toxoplasma gondii | aldose reductase, putative | 0.0036 | 0.0108 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.019 | 0.019 |
Echinococcus granulosus | hypothetical protein | 0.0036 | 0.0108 | 0.0128 |
Trypanosoma cruzi | aldo-keto reductase | 0.0036 | 0.0108 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.019 | 1 |
Brugia malayi | hypothetical protein | 0.0286 | 0.2728 | 1 |
Trichomonas vaginalis | aldo/keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Echinococcus granulosus | aldo keto reductase | 0.0036 | 0.0108 | 0.0128 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0166 | 0.0221 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 0.8471 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0036 | 0.0108 | 0.0108 |
Mycobacterium leprae | PROBABLE ISOCITRATE LYASE AceA (ISOCITRASE) (ISOCITRATASE) (ICL) | 0.0594 | 0.596 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0833 | 0.8471 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0036 | 0.0108 | 0.0128 |
Echinococcus granulosus | aldo keto reductase | 0.0036 | 0.0108 | 0.0128 |
Leishmania major | aldehyde reductase, putative,oxidoreductase, putative | 0.0036 | 0.0108 | 0.5 |
Echinococcus multilocularis | aldo keto reductase | 0.0036 | 0.0108 | 0.0108 |
Trypanosoma brucei | prostaglandin f synthase | 0.0036 | 0.0108 | 0.5 |
Mycobacterium tuberculosis | Isocitrate lyase Icl (isocitrase) (isocitratase) | 0.0594 | 0.596 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.2728 | 0.2728 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Mycobacterium tuberculosis | Probable isocitrate lyase AceAb [second part] (isocitrase) (isocitratase) (Icl) | 0.0594 | 0.596 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0345 | 0.0284 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0036 | 0.0108 | 0.0108 |
Trichomonas vaginalis | dihydrodiol dehydrogenase, putative | 0.0036 | 0.0108 | 0.5 |
Echinococcus granulosus | aldo keto reductase | 0.0036 | 0.0108 | 0.0128 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Brugia malayi | RNA binding protein | 0.0076 | 0.0537 | 0.1636 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0537 | 0.0512 |
Brugia malayi | hypothetical protein | 0.0043 | 0.019 | 0.0313 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0345 | 0.0905 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.019 | 0.0225 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0366 | 0.0984 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0036 | 0.0108 | 0.5 |
Mycobacterium ulcerans | isocitrate lyase Icl | 0.0594 | 0.596 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.0537 | 0.1636 |
Leishmania major | aldo-keto reductase-like protein | 0.0036 | 0.0108 | 0.5 |
Mycobacterium ulcerans | isocitrate lyase AceAb | 0.0594 | 0.596 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.0537 | 0.1636 |
Mycobacterium leprae | Isocitrate lyase | 0.0278 | 0.2653 | 0.4451 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0036 | 0.0108 | 0.0108 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0036 | 0.0108 | 0.0128 |
Echinococcus multilocularis | aldo keto reductase | 0.0036 | 0.0108 | 0.0108 |
Leishmania major | prostaglandin f synthase, putative | 0.0036 | 0.0108 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.0537 | 0.0537 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.0537 | 0.1636 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0036 | 0.0108 | 0.0108 |
Leishmania major | prostaglandin f2-alpha synthase/D-arabinose dehydrogenase | 0.0036 | 0.0108 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 4.4668 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 5.0119 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.2213 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 7.9433 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 12.9953 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | = 100 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (binding) | 251.1886 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.